Additional sector guidance – Biotechnology and pharmaceuticals
Detalles
This document provides additional guidance in the pharmaceutical and biotechnology sector. This covers: The assessment of nature-related issues using the TNFD's LEAP approach and the disclosure of sector-specific metrics in line with the approach recommended by the TNFD.
Recursos relacionados
State of Finance for Nature 2023
For the first time, this edition of the report estimates the magnitude of nature-negative financial flows from both public and…
Nature-related Financial Risks: a Conceptual Framework to guide Action by Central Banks and Supervisors
This paper aims to create a common language and scientific understanding of nature-related financial risks among members of the Network…
Report on the 2023 Taxonomy Report
After two years of disclosure of information on Taxonomy, many questions arise about the usefulness of this information. This document…